Signaling Pathways - RET - MER - Aldosterone receptor - LPA Receptors
清除全部
- B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂
- B7515 1-Oleoyl lysophosphatidic acid sodium saltTarget: LPA ReceptorsSummary: 激活LPA受体
- B1591 Ki16198Target: LPA ReceptorsSummary: LPA拮抗剂
- A8506 Potassium CanrenoateTarget: Aldosterone receptorSummary: 醛固酮拮抗剂
- A1987 Ki164254 CitationTarget: LPA ReceptorsSummary: LPA受体拮抗剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂
- A3170 AM9662 CitationTarget: LPA ReceptorsSummary: LPA1拮抗剂
- A3167 AM-095 free baseTarget: LPA ReceptorsSummary: 有效的LPA1受体拮抗剂